RYR2 and catecholaminergic polymorphic ventricular tachycardia: However, it failed to present cardioprotective effects on catecholamine-induced DADs and arrhythmia generation in the R4496C+/- mouse model of CPVT with a mutation in the RyR2 transmembrane domain [26].